- Home
- BODI vs KALA Comparison
BODI vs KALA Comparison
Compare BODI & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- KALA
- Stock Information
- Founded
- BODI 1998
- KALA 2009
- Country
- BODI United States
- KALA United States
- Employees
- BODI N/A
- KALA N/A
- Industry
- BODI Industrial Machinery/Components
- KALA Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- KALA Health Care
- Exchange
- BODI Nasdaq
- KALA Nasdaq
- Market Cap
- BODI 28.3M
- KALA 26.2M
- IPO Year
- BODI N/A
- KALA 2017
- Fundamental
- Price
- BODI $3.65
- KALA $4.14
- Analyst Decision
- BODI Strong Buy
- KALA Strong Buy
- Analyst Count
- BODI 3
- KALA 3
- Target Price
- BODI $10.67
- KALA $14.00
- AVG Volume (30 Days)
- BODI 27.0K
- KALA 41.9K
- Earning Date
- BODI 08-05-2025
- KALA 05-14-2025
- Dividend Yield
- BODI N/A
- KALA N/A
- EPS Growth
- BODI N/A
- KALA N/A
- EPS
- BODI N/A
- KALA N/A
- Revenue
- BODI $371,113,000.00
- KALA N/A
- Revenue This Year
- BODI N/A
- KALA N/A
- Revenue Next Year
- BODI N/A
- KALA N/A
- P/E Ratio
- BODI N/A
- KALA N/A
- Revenue Growth
- BODI N/A
- KALA N/A
- 52 Week Low
- BODI $3.38
- KALA $2.92
- 52 Week High
- BODI $9.40
- KALA $11.20
- Technical
- Relative Strength Index (RSI)
- BODI 39.67
- KALA 55.51
- Support Level
- BODI $3.50
- KALA $3.50
- Resistance Level
- BODI $3.89
- KALA $4.40
- Average True Range (ATR)
- BODI 0.30
- KALA 0.36
- MACD
- BODI 0.03
- KALA 0.08
- Stochastic Oscillator
- BODI 24.04
- KALA 71.11
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.